NuCana (NCNA) Projected to Post Earnings on Wednesday

NuCana (NASDAQ:NCNA) is expected to be posting its quarterly earnings results before the market opens on Wednesday, March 19th. Analysts expect NuCana to post earnings of ($2.43) per share for the quarter.

NuCana Trading Down 4.8 %

NuCana stock opened at $0.76 on Monday. The firm has a 50 day simple moving average of $1.00 and a 200 day simple moving average of $1.64. The firm has a market capitalization of $2.01 million, a price-to-earnings ratio of -0.07 and a beta of 0.89. NuCana has a 1-year low of $0.75 and a 1-year high of $10.79.

NuCana Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells.